'Product Red' is the private sector's bid to fight HIV. But is it too little too late? Colin Macilwain investigates.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional information
See Editorial, page 723. Product Red→ http://www.joinred.com
Related links
Related links
Related links in Nature Research
AIDS treatment: Staying the course
Related external links
Rights and permissions
About this article
Cite this article
A firm response to AIDS. Nature 443, 738–739 (2006). https://doi.org/10.1038/443738a
Published:
Issue Date:
DOI: https://doi.org/10.1038/443738a